CLINICAL ROLE -
Updated C. Difficile Infection Guidelines Incorporate New Trials
Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
Semaglutide is a Promising Drug Treatment for Chronic Weight Management
Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.
2 Clarke Drive Cranbury, NJ 08512